Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
17.67
0.00 (0.00%)
At close: Dec 31, 2025, 4:00 PM EST
17.66
-0.01 (-0.06%)
Pre-market: Jan 2, 2026, 8:00 AM EST
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.15 billion as of January 2, 2026. Its market cap has increased by 90.28% in one year.
Market Cap
1.15B
Enterprise Value
1.11B
1-Year Change
90.28%
Ranking
Category
Stock Price
$17.67
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.15B, an increase of 790.26%. That is a compound annual growth rate of 8.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |